Kesmalea Therapeutics ApS — Credit Rating and Financial Key Figures

Kesmalea Therapeutics ApS (CVR number: 41804505) is a company from KØBENHAVN. The company recorded a gross profit of -3110.7 kDKK in 2021. The operating profit was -3110.7 kDKK, while net earnings were -3314.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was -84 %, which can be considered poor and Return on Equity (ROE) was -775.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -88.5 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Kesmalea Therapeutics ApS's liquidity measured by quick ratio was 28.5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.